Unilife Corp (UNIS) 3.04 $UNIS
Unilife Corporation Announces Financial Results For Fiscal Year 2014 Third Quarter
PR Newswire - Mon May 12, 3:07PM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended March 31, 2014, ("the third quarter of Fiscal Year 2014" or "Current Quarter" .
Health Care Sector Stocks Technical Data -- Research on Bacterin International Holdings, Align Technology, Endologix, and Unilife
PR Newswire - Mon May 12, 11:30AM CDT
On Friday, May 09, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average finished the session at 16,583.34, up 0.20% and the S&P 500 closed at 1,878.48, up 0.15%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, and the index has gained 3.66% in the previous one month. Investor-Edge has initiated coverage on the following equities: Bacterin International Holdings Inc. (NYSE MKT: BONE), Align Technology Inc. (NASDAQ: ALGN), Endologix Inc. (NASDAQ: ELGX) and Unilife Corp. (NASDAQ: UNIS). Free technical research on BONE, ALGN, ELGX and UNIS can be downloaded upon signing up at:
Unilife Appoints John Ryan as Senior Vice President, General Counsel and Secretary
PR Newswire - Thu May 08, 11:15AM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS), a leader for differentiated injectable drug delivery systems, today announced the appointment of John Ryan, J.D. as Senior Vice President, General Counsel and Secretary. Christopher Naftzger, J.D., who has been Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer since 2010, will remain at Unilife and assumes the position of Vice President of Legal Affairs.
Unilife Corporation To Announce Financial Results For Fiscal Year 2014 Third Quarter On Monday, May 12, 2014
PR Newswire - Wed Apr 30, 8:00AM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2014 third quarter ended March 31, 2014 after market trading ends on Monday, May 12, 2014.
Unilife Corporation (UNIS) Hits Back at Short-Sellers
at The Street - Wed Apr 23, 2:32PM CDT
Unilife Corporation (UNIS) has issued a response to a series of articles published against the company this week.
Weakness Seen in Unilife (UNIS): Stock Tumbles 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:49AM CDT
Unilife Corporation (UNIS) saw a big move last session,continuing the recent downtrend for URS, as the stock is now down around 34.50% in the past one-month time frame.
Unilife Responds to Malicious Blogs
PR Newswire - Tue Apr 22, 6:40PM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS) today issued a response on behalf of its shareholders in relation to a series of malicious blogs containing false and misleading information published over recent months by short sellers on the Seeking Alpha website.
Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Commit To Purchase Unilife Corp. At $2.50, Earn 13.4% Annualized Using Options
StockOptionsChannel.com - Thu Apr 10, 10:51AM CDT
Investors eyeing a purchase of Unilife Corp. shares, but cautious about paying the going market price of $3.62/share, might benefit from considering selling puts among the alternative strategies at their disposal.
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer
ACCESSWIRE - Fri Apr 04, 1:00PM CDT
Exelixis Inc. (NASDAQ:EXEL) enjoyed robust stock volume Apr. 3, with 4,756,727 shares changing hands.
Unilife Down 5.1%, Shares Slide into the Red (UNIS)
Comtex SmarTrend(R) - Fri Mar 28, 10:41AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 5.1% to $4.11 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-5.1% to the Dow's 0.7%) and underperformed the S&P 500 (-5.1% to the S&P's 0.8%) during today's trading.
Investors look to Lighten Up on Shares of Unilife, Shares Down 8.5% (UNIS)
Comtex SmarTrend(R) - Mon Mar 24, 11:42AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 8.5% to $4.75 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-8.5% to the Dow's -0.5%) and underperformed the S&P 500 (-8.5% to the S&P's -0.8%) during today's trading.
Nasdaq stocks posting largest percentage decreases
AP - Thu Mar 20, 12:54PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Top Gainers Technical Data -- Research on First Solar, Oncothyreon, Unilife, and Synthetic Biologics
PR Newswire - Thu Mar 20, 7:07AM CDT
The US markets saw a negative sentiment on Wednesday, March 19, 2014, with the NASDAQ Composite closing at 4,307.60, down 0.59%, the Dow Jones Industrial Average ending the session at 16,222.17, down 0.70% and the S&P 500 edging 0.61% lower to finish the trading session at 1,860.77. The losses were broad based as all the ten sectors ended the session in negative. A number of stocks saw large movements, including First Solar Inc. (NASDAQ: FSLR), Oncothyreon Inc. (NASDAQ: ONTY), Unilife Corp. (NASDAQ: UNIS), and Synthetic Biologics Inc. (AMEX: SYN). Free technical research on FSLR, ONTY, UNIS, and SYN can be downloaded upon signing up at:
Unilife hires Dennis Pyers as interim CFO
M2 - Wed Mar 19, 8:28AM CDT
Drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) disclosed on Tuesday that Dennis Pyers (CPA) has been elected as its interim CFO.
Agreements, Financial Results, Clinical Study Results, Debt Financing, and Drug Application Updates - Analyst Notes on Tesaro, Chelsea Therapeutics, Venaxis, Geron, and Unilife
PR Newswire - Wed Mar 19, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Tesaro, Inc. (NASDAQ: TSRO), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Venaxis, Inc. (NASDAQ: APPY), Geron Corporation (NASDAQ: GERN), and Unilife Corporation (NASDAQ: UNIS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Unilife Appoints Dennis Pyers as Interim CFO
PR Newswire - Tue Mar 18, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company" (NASDAQ: UNIS, ASX: UNS) today announced that Mr. Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Mr. Pyers replaces Mr. Richard Wieland who is leaving Unilife after four years as Executive Vice President and Chief Financial Officer.
Unilife Corporation Announces Financial Results For Fiscal Year 2014 Third Quarter
PR Newswire - Mon May 12, 3:07PM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS), a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended March 31, 2014, ("the third quarter of Fiscal Year 2014" or "Current Quarter" . Health Care Sector Stocks Technical Data -- Research on Bacterin International Holdings, Align Technology, Endologix, and Unilife
PR Newswire - Mon May 12, 11:30AM CDT
On Friday, May 09, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average finished the session at 16,583.34, up 0.20% and the S&P 500 closed at 1,878.48, up 0.15%. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 668.35, up 0.58%, and the index has gained 3.66% in the previous one month. Investor-Edge has initiated coverage on the following equities: Bacterin International Holdings Inc. (NYSE MKT: BONE), Align Technology Inc. (NASDAQ: ALGN), Endologix Inc. (NASDAQ: ELGX) and Unilife Corp. (NASDAQ: UNIS). Free technical research on BONE, ALGN, ELGX and UNIS can be downloaded upon signing up at:
Unilife Appoints John Ryan as Senior Vice President, General Counsel and Secretary
PR Newswire - Thu May 08, 11:15AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS), a leader for differentiated injectable drug delivery systems, today announced the appointment of John Ryan, J.D. as Senior Vice President, General Counsel and Secretary. Christopher Naftzger, J.D., who has been Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer since 2010, will remain at Unilife and assumes the position of Vice President of Legal Affairs. Unilife Corporation To Announce Financial Results For Fiscal Year 2014 Third Quarter On Monday, May 12, 2014
PR Newswire - Wed Apr 30, 8:00AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2014 third quarter ended March 31, 2014 after market trading ends on Monday, May 12, 2014. Unilife Corporation (UNIS) Hits Back at Short-Sellers
at The Street - Wed Apr 23, 2:32PM CDT
Unilife Corporation (UNIS) has issued a response to a series of articles published against the company this week.
Weakness Seen in Unilife (UNIS): Stock Tumbles 10.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:49AM CDT
Unilife Corporation (UNIS) saw a big move last session,continuing the recent downtrend for URS, as the stock is now down around 34.50% in the past one-month time frame.
Unilife Responds to Malicious Blogs
PR Newswire - Tue Apr 22, 6:40PM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS) today issued a response on behalf of its shareholders in relation to a series of malicious blogs containing false and misleading information published over recent months by short sellers on the Seeking Alpha website. Global Prefilled Syringes Market 2013 - 2019
M2 - Tue Apr 15, 8:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/j3vxcv/prefilled) has announced the addition of the "Global Prefilled Syringes Market 2013 - 2019" report to their offering. The two major segments described in this study are glass-based and plastic-based prefilled syringes. Each of these segments has been analyzed on the basis of their current and future market size in terms of USD million and market volume in terms of million units, considering the macro and micro environmental factors. In addition, the compounded annual growth rate (CAGR) of the overall market and the above segments has also been provided in the report for the forecast period 2013 to 2019, considering 2012 as the base year. Geographically, the market for prefilled syringes has been classified into four regions namely North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each of these regions along with CAGR has also been provided in the report. A detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter's five forces analysis and market attractiveness analysis are discussed in the market overview section of the report. The study also suggests a list of recommendations that is likely to help manufacturers in decision making process. The report concludes with a market share analysis of the leading players in the market for prefilled syringes, in terms of percentage share in the year 2012, and company profiles of the key players. The market players profiled in this report are Becton, Dickinson and Company, Gerresheimer AG, Nipro Corporation, Schott AG, Stevanato Group, Baxter, International, Inc., Unilife Corporation, West Pharmaceutical Services, Inc., Bespak, Ypsomed Holding AG and Vetter Pharma International GmbH. Scope of the Report Segment - Glass Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) - Plastic Prefilled Syringes Market - - By Revenue (USD Million) - - By Volume (Million units) Key Topics Covered: - Preface - Executive Summary - Global Prefilled Syringes Market Overview - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Segment, 2011 - 2019 - Global Prefilled Syringes Market Revenue (USD Million) and Volume (Million Units), by Geography, 2011 - 2019 - Competitive Landscape - Recommendations - Company Profiles - Baxter International, Inc - Becton, Dickinson & Company - Bespak - Gerresheimer AG - Nipro Corporation - Schott AG - Stevanato Group - Unilife Corporation - Vetter Pharma International GmbH - West Pharmaceutical Services, Inc - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/j3vxcv/prefilled
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Commit To Purchase Unilife Corp. At $2.50, Earn 13.4% Annualized Using Options
StockOptionsChannel.com - Thu Apr 10, 10:51AM CDT
Investors eyeing a purchase of Unilife Corp. shares, but cautious about paying the going market price of $3.62/share, might benefit from considering selling puts among the alternative strategies at their disposal.
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer
ACCESSWIRE - Fri Apr 04, 1:00PM CDT
Exelixis Inc. (NASDAQ:EXEL) enjoyed robust stock volume Apr. 3, with 4,756,727 shares changing hands.
Unilife Down 5.1%, Shares Slide into the Red (UNIS)
Comtex SmarTrend(R) - Fri Mar 28, 10:41AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 5.1% to $4.11 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-5.1% to the Dow's 0.7%) and underperformed the S&P 500 (-5.1% to the S&P's 0.8%) during today's trading.
Investors look to Lighten Up on Shares of Unilife, Shares Down 8.5% (UNIS)
Comtex SmarTrend(R) - Mon Mar 24, 11:42AM CDT
Unilife (NASDAQ:UNIS) is one of today's worst performing low-priced stocks, down 8.5% to $4.75 on 1.1x average daily volume. Unilife has traded 1.3 million shares thus far today, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-8.5% to the Dow's -0.5%) and underperformed the S&P 500 (-8.5% to the S&P's -0.8%) during today's trading.
Nasdaq stocks posting largest percentage decreases
AP - Thu Mar 20, 12:54PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
Top Gainers Technical Data -- Research on First Solar, Oncothyreon, Unilife, and Synthetic Biologics
PR Newswire - Thu Mar 20, 7:07AM CDT
The US markets saw a negative sentiment on Wednesday, March 19, 2014, with the NASDAQ Composite closing at 4,307.60, down 0.59%, the Dow Jones Industrial Average ending the session at 16,222.17, down 0.70% and the S&P 500 edging 0.61% lower to finish the trading session at 1,860.77. The losses were broad based as all the ten sectors ended the session in negative. A number of stocks saw large movements, including First Solar Inc. (NASDAQ: FSLR), Oncothyreon Inc. (NASDAQ: ONTY), Unilife Corp. (NASDAQ: UNIS), and Synthetic Biologics Inc. (AMEX: SYN). Free technical research on FSLR, ONTY, UNIS, and SYN can be downloaded upon signing up at:
Unilife hires Dennis Pyers as interim CFO
M2 - Wed Mar 19, 8:28AM CDT
Drug delivery company Unilife (NASDAQ:UNIS)(ASX:UNS) disclosed on Tuesday that Dennis Pyers (CPA) has been elected as its interim CFO.
Agreements, Financial Results, Clinical Study Results, Debt Financing, and Drug Application Updates - Analyst Notes on Tesaro, Chelsea Therapeutics, Venaxis, Geron, and Unilife
PR Newswire - Wed Mar 19, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Tesaro, Inc. (NASDAQ: TSRO), Chelsea Therapeutics International Ltd. (NASDAQ: CHTP), Venaxis, Inc. (NASDAQ: APPY), Geron Corporation (NASDAQ: GERN), and Unilife Corporation (NASDAQ: UNIS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Unilife Appoints Dennis Pyers as Interim CFO
PR Newswire - Tue Mar 18, 7:00AM CDT
Unilife Corporation ("Unilife" or "Company"
(NASDAQ: UNIS, ASX: UNS) today announced that Mr. Dennis Pyers, Vice-President and Controller of Unilife since 2010, has been named Interim CFO. Mr. Pyers replaces Mr. Richard Wieland who is leaving Unilife after four years as Executive Vice President and Chief Financial Officer. 
